as an eluent gave 2.61 g (66%) of 7a as a white solid consisting of
isomers 10a(I) and 10a(II). 10a(I): d (500.13 MHz; CDCl ): 0.64
3H, s, 18-CH ), 0.92 (3H, s, 19-
), 0.90 (3H, d, J = 6.5 Hz, 21-CH
CH ), 2.38-1.00 (m, 23-CH , steroidal-CH and -CH), 3.66 (s, 6H,
5-CH ), 3.80-3.65 (m, 8H, 26-CH , 28-CH , 26¢-CH , 28¢-CH );
(125.7 MHz; CDCl ): 12.0 (C18), 18.3 (C21), 21.1 (C11), 23.2
structure of one isomer resolved. The bile acid substituent in the
dioxane ring seems to not disable the conformational changes in
the flexibility of the dioxane rings. In the future it will be interesting
to study whether the diketals could be crystallized also in the other
conformations and to compare the properties of these crystals.
Finally, the bile acid-derived acetals may serve as model structures
for preparation of novel prodrugs with the bile acid moiety aimed
for enhanced drug uptake or liver targeting.
H
3
(
3
3
3
2
2
2
d
3
2
2
2
2
C
3
(
C19), 24.2 (C15), 26.3 (C7), 26.8 (C6), 27.1 (C2), 28.2 (C16), 31.0,
3
1.1 (C22, C23), 32.6 (C1), 33.0 (C27), 33.3 (C4), 35.4 (C20), 35.7
(
C8), 39.4 (C9), 39.8 (C5), 35.0 (C10), 40.2 (C12), 42.8 (C13), 51.4
(
1
1
C25), 56.0 (C17), 56.5 (C14), 63.6, 63.3 (C26, C28, C26¢, C28¢),
-
1
00.1 (C3), 174.7 (C24); vmax/cm : 2923, 2850, 1734, 1439, 1365,
Acknowledgements
+
177, 1150, 1081, 1028, 998, 873, 732, 606, 423; MS (ES ), found
+
+
The authors wish to thank Spec. Lab. Tech. Reijo Kauppinen
for his help in running the NMR spectra, and Lab. Tech. Elina
Hautakangas for elemental analysis. Financial support from the
Finnish Ministry of Education, National Graduate School of
Organic Chemistry and Chemical Biology (S. Ikonen) and from the
Academy of Finland (project no. 121805, Nonappa) is gratefully
acknowledged.
m/z: 899.67 ([M+Na] ) and 915.61 ([M+K] ). Found: C 73.41, H
·H O requires C 73.79, H 10.13%.
9
.84; C55
H
88
O
8
2
1
0a(II).
d
H
(500.13 MHz; CDCl
), 0.92 (3H, s, 19-CH
and -CH), 3.66 (6H, s, 25-CH
, 28-CH , 26¢-CH , 28¢-CH , H
= 3.79 J = 13.7 Hz, H = 3.66, H
(125.7 MHz; CDCl ): 12.0 (C18), 18.3 (C21), 21.1 (C11), 23.1
3
): 0.64 (3H, s, 18-CH
3
), 0.90
(
2
3
H
d
(
(
(
3H, d, J = 6.5 Hz, 21-CH
3
3
), 2.38-1.00 (m,
3-CH
2
, steroidal -CH
2
3
), 3.82-
.62 (8H, 2 ¥ qAB, 26-CH
a
2
2
2
2
b
= 3.80
b
a
= 3.64 J = 11.6 Hz);
C
3
Notes and references
C19), 24.2 (C15), 26.2 (C7), 26.7 (C2, C6), 28.2 (C16), 31.1, 31.0
C23, C22), 32.6 (C1), 33.7 (C4), 35.0 (C10), 35.4 (C20), 35.7
C8), 39.4 (C9), 40.2 (C12), 40.2 (C5), 42.8 (C13), 51.4 (C25), 56.0
C17), 56.5 (C14), 63.6, 63.3 (C26, C28, C26¢, C28¢), 99.7 (C3),
74.7 (C24); vmax/cm : 2928, 2853, 1737, 1447, 1377, 1166, 1078,
022, 873, 608, 527, 423; Found: C 74.37, H 9.94; C30
1
(a) J.-M. Lehn, Supramolecular Chemistry: Concepts and Perspectives,
VCH, Weinheim, Germany, 1995; (b) Molecular Self-Assembly, Struc-
ture and Bonding, ed. M. Fujita, Springer, Berlin, 2000, vol. 96; (c) The
Crystal as a Supramolecular Entity, Perspectives in Supramolecular
Chemistry, ed. G. R. Desiraju, Wiley, Chichester, U.K., 1995, vol. 2;
(
1
1
-
1
1
2
H
46
O
8
· H
2
O
(
d) M. D. Hollingsworth, Science, 2002, 295, 2410–2413.
2 (a) I. Grosu, S. Mager and G. Ple, J. Chem. Soc., Perkin Trans. 2,
995, 1351–1357; (b) I. Grosu, S. Mager, G. Ple, I. Turos, E. Mesaros
requires C 74.53, H 10.12%.
1
and I. Schirger, Monatsch. Chem., 1998, 129, 59–68; (c) A. Mihis, E.
Condamine, E. Bogdan, A. Terec, T. Kurtan and I. Grosu, Molecules,
Conclusions
2
008, 13, 2848–2858.
3
4
N. G. Lemcoff and B. Fuchs, Org. Lett., 2002, 4, 731–734.
Novel bile acid-derived monoketals with 1,2-benzenediol (cate-
chol) and 2,3-naphthalenediol as well as mono- and diketals with
pentaerythritol have been prepared and characterized. Monoke-
tals of pentaerythritol showed a tendency to form thermoreversible
gels in many aromatic solvents and the methyl lithocholate
derivative proved to be a supergelator able to form a gel in
t-butylbenzene at a concentration of 0.5% w/v. While most of
the bile acid-derived organogelators have the amide functionality
in their side chain, the type of organogelators presented here are
rare. It is thus interesting to further study the interactions and
the nucleation process required for the formation of the gel by
these and other similar LMOGs. Because of the biocompatibility
of the bile acid moiety, the gels derived from their derivatives
may find applications in the fields of supramolecular biochemistry
or biomedicinal chemistry. Furthermore, these monoketals may
serve as model compounds for a wide variety of similar bile
acid derivatives with organogelling fuctionality. Whereas the
naphthalenediol ketal 9a formed film-type materials in the studied
solvents, the catechol ketals underwent rapid crystallization to
X-ray quality single crystals and their crystal structures were
determined. Interestingly, very small changes in the steroidal part
induced completely different kinds of packing in the crystals
of 7a and 7c. The monoketal 7c, obtained from methyl-3,7,12-
trioxocholanoate (cholic acid derivative), revealed to have a
packing pattern which is very unusual for bile acid derivatives.
Formation of diketals of pentaerythritol always produced a
mixture of two diastereomers which, in the case of the methyl
lithocholate derivative, have been separated and the X-ray crystal
(a) I. Grosu, E. Bogdan, G. Ple, L. Toupet, Y. Ramondenc, E.
Condamine, V. Peulon-Agasse and M. Balog, Eur. J. Org. Chem., 2003,
3153–3161; (b) M. Balog, I. Grosu, G. Ple, Y. Ramondenc, L. Toupet,
E. Condamine, C. Lange, C. Loutelier-Bourhis, V. Peulon-Agasse and
E. Bogdan, Tetrahedron, 2004, 60, 4789–4799.
5
(a) H. A. Stanbury, and H. R. Guest, US Patent, US19570716, 1962.;
(b) D. B. Capps, US Patent, US2889290, 1959; (c) E. H. Pryde, R. A.
Awl, H. M. Teeter and J. C. Cowan, J. Org. Chem., 1960, 25, 2260–2261;
(
(
d) S. M. Cohen and E. Lavin, J. Appl. Polym. Sci., 1962, 6, 503–507;
e) M. S. Cohen, C. F. Hunt, R. E. Kass and A. H. Markhart, J. Appl.
Polym. Sci., 1962, 6, 508–517; (f) S. M. Cohen, and E. Lavin, US Patent,
US19570610, 1962.; (g) A. H. Markhart, C. F. Hunt, and E. Lavin, US
Patent, US19580811, 1962.; (h) W. J. Bailey and A. A. Volpe, J. Polym.
Sci., Part A-1, 1970, 8, 2109–2122; (i) F. V. Zalar, Macromolecules, 1972,
5
, 539–541; (j) S. Makhseed and N. B. McKeown, Chem. Commun.,
1999, 255–256.
6 (a) P. Wessig, K. M o¨ llnitz and C. Eiserbeck, Chem.–Eur. J., 2007, 13,
4
4
859–4872; (b) P. Wessig and K. M o¨ llnitz, J. Org. Chem., 2008, 73,
452–4457; (c) P. Mueller, J. Nikolaus, S. Schiller, A. Herrmann, K.
Moellnitz, S. Czapla and P. Wessig, Angew. Chem., Int. Ed., 2009, 48,
4433–4435.
7
8
9
(a) P. F. H. Schwab, J. R. Smith and J. Michl, Chem. Rev., 2005, 105,
1
1
197–1280; (b) P. F. H. Schwab, M. D. Levin and J. Michl, Chem. Rev.,
999, 99, 1863–1934.
H. Danielsson, in The Bile Acids: Chemistry, Physiology and
Metabolism, ed. P. P. Nair and D. Kritchevsky, Plenum Press, New
York, 1973, vol. 2, pp. 1-32.
(a) A. Enhsen, W. Kramer and G. Wess, Drug Discovery Today, 1998,
3
, 409–418; (b) S. Mukhopadhyay and U. Maitra, Curr. Sci., 2004, 87,
1666–1683; (c) A. F. Hofmann and L. R. Hagey, Cell. Mol. Life Sci.,
008, 65, 2461–2483.
2
1
0 (a) J. Tamminen and E. Kolehmainen, Molecules, 2001, 6, 21–46; (b) E.
Virtanen and E. Kolehmainen, Eur. J. Org. Chem., 2004, 3385–3399;
(
c) A. P. Davis, Molecules, 2007, 12, 2106–2122; (d) Nonappa and U.
Maitra, Org. Biomol. Chem., 2008, 6, 657–669.
This journal is © The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 2784–2794 | 2793